Bionano Genomics, Inc. (LON:0A4K)

Market Cap	8.50M -10.5%
Revenue (ttm)	21.37M -13.8%
Net Income	-28.71M
EPS	-8.74
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,768
Average Volume	9,566
Open	5.70
Previous Close	5.58
Day's Range	5.19 - 5.88
52-Week Range	5.00 - 80.86
Beta	n/a
RSI	28.30
Earnings Date	Mar 12, 2026

About Bionano Genomics

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome anal...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4K

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD